Your browser doesn't support javascript.
loading
Penile calciphylaxis: A retrospective case-control study.
Gabel, Colleen; Chakrala, Teja; Shah, Radhika; Danesh, Melissa J; Dobry, Allison S; Garza-Mayers, Anna Cristina; Ko, Lauren N; Nguyen, Emily; St John, Jessica; Walls, Andrew C; Nigwekar, Sagar U; Song, Philip I; Kroshinsky, Daniela.
Afiliação
  • Gabel C; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • Chakrala T; Narayana Medical College and Hospital, Nellore, India.
  • Shah R; Department of Dermatology, Robert Wood Johnson Medical School, New Brunswick.
  • Danesh MJ; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
  • Dobry AS; Department of Dermatology, University of California, Irvine School of Medicine, Irvine, California.
  • Garza-Mayers AC; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
  • Ko LN; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.
  • Nguyen E; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.
  • St John J; Department of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts.
  • Walls AC; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Nigwekar SU; Department of Nephrology, Massachusetts General Hospital, Boston, Massachusetts.
  • Song PI; Department of Dermatology, Palo Alto Medical Foundation, Palo Alto, California.
  • Kroshinsky D; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: dkroshinsky@partners.org.
J Am Acad Dermatol ; 85(5): 1209-1217, 2021 11.
Article em En | MEDLINE | ID: mdl-32422224
ABSTRACT

BACKGROUND:

Calciphylaxis is a rare disorder characterized by skin necrosis caused by calcium deposition within vessels, thrombosis, and subsequent tissue ischemia. Penile involvement may rarely occur.

OBJECTIVE:

To identify risk factors, diagnosis, management, and mortality of patients with penile calciphylaxis.

METHODS:

A retrospective medical record review was conducted of 16 patients with penile calciphylaxis treated at 2 large urban tertiary care centers between January 2001 and December 2019. A control group of 44 male patients with nonpenile calciphylaxis at the same institution was included.

RESULTS:

The median survival of patients with penile calciphylaxis was 3.8 months (interquartile range, 27.0 months). Mortality was 50% at 3 months and 62.5% at 6 months for penile calciphylaxis, and 13.6% at 3 months and 29.5% at 6 months for controls (P = .008). Patients with penile calciphylaxis were less likely to be obese (P = .04) but more likely to have hyperparathyroidism (P = .0003) and end-stage renal disease (P = .049).

LIMITATIONS:

Retrospective study design and small sample size.

CONCLUSIONS:

This study further defines the disease course of penile calciphylaxis, which has high mortality. Imaging may be used to aid diagnosis. Risk factors include end-stage renal disease, hyperparathyroidism, and normal body mass index.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Calciofilaxia Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Calciofilaxia Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article